Goldman Sachs’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.32M Sell
7,000
-19,200
-73% -$4.05M ﹤0.01% 4884
2025
Q4
$5.21M Sell
26,200
-37,900
-59% -$7.66M ﹤0.01% 3703
2025
Q3
$13M Buy
64,100
+24,000
+60% +$4.26M ﹤0.01% 2710
2025
Q2
$7.06M Sell
40,100
-25,000
-38% -$3.76M ﹤0.01% 3087
2025
Q1
$8.76M Hold
65,100
﹤0.01% 2818
2024
Q4
$8.22M Hold
65,100
﹤0.01% 2980
2024
Q3
$10.8M Buy
65,100
+25,100
+63% +$3.8M ﹤0.01% 2630
2024
Q2
$5.32M Buy
+40,000
New +$4.82M ﹤0.01% 3091
2019
Q3
Sell
-894,900
Closed -$18.5M 5378
2019
Q2
$18.5M Buy
+894,900
New +$20.6M 0.01% 1914
2018
Q4
Sell
-1,600
Closed -$46K 5659
2018
Q3
$46K Hold
1,600
﹤0.01% 5308
2018
Q2
$54K Sell
1,600
-100
-6% -$3.11K ﹤0.01% 5341
2018
Q1
$41K Sell
1,700
-66,700
-98% -$1.33M ﹤0.01% 5533
2017
Q4
$1.04M Sell
68,400
-188,500
-73% -$2.65M ﹤0.01% 4302
2017
Q3
$4.22M Buy
256,900
+148,000
+136% +$2.51M ﹤0.01% 3316
2017
Q2
$2.11M Buy
108,900
+29,900
+38% +$522K ﹤0.01% 3795
2017
Q1
$1.4M Sell
79,000
-462,700
-85% -$8.58M ﹤0.01% 4076
2016
Q4
$8.04M Sell
541,700
-8,400
-2% -$151K ﹤0.01% 2634
2016
Q3
$12.5M Buy
550,100
+42,100
+8% +$1.1M ﹤0.01% 2273
2016
Q2
$14M Buy
508,000
+2,800
+0.6% +$82.7K ﹤0.01% 2067
2016
Q1
$14.6M Sell
505,200
-32,900
-6% -$856K ﹤0.01% 1946
2015
Q4
$16.3M Buy
538,100
+441,400
+456% +$14.5M 0.01% 1899
2015
Q3
$3.57M Sell
96,700
-614,000
-86% -$31.7M ﹤0.01% 3199
2015
Q2
$41.1M Buy
710,700
+646,300
+1,004% +$33M 0.01% 1249
2015
Q1
$3.19M Sell
64,400
-50,200
-44% -$2.35M ﹤0.01% 3332
2014
Q4
$5.81M Sell
114,600
-158,800
-58% -$8.3M ﹤0.01% 2856
2014
Q3
$16.2M Sell
273,400
-1,900
-0.7% -$106K 0.01% 1958
2014
Q2
$12.9M Buy
275,300
+191,300
+228% +$8.64M ﹤0.01% 2159
2014
Q1
$3.6M Buy
84,000
+12,400
+17% +$547K ﹤0.01% 3406
2013
Q4
$3.02M Buy
71,600
+18,800
+36% +$819K ﹤0.01% 3628
2013
Q3
$2.17M Buy
52,800
+10,000
+23% +$418K ﹤0.01% 3835
2013
Q2
$1.97M Buy
+42,800
New +$1.92M ﹤0.01% 3749

Other funds holding THC

Goldman Sachs's THC Position: Q1 2026 in Review

Goldman Sachs increased its Tenet Healthcare (THC) stake by 21% in Q1 2026, buying an estimated $14.6M and bringing the position to 404,257 shares worth $76.3M. The position accounts for 0.01% of the portfolio, ranked #1236.

Goldman Sachs first reported a position in THC in Q2 2013 and has held it in 52 quarters since. The position peaked at $211M in Q4 2013. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Goldman Sachs held 404,257 shares of Tenet Healthcare worth $76.3M as of Q1 2026.
  • Goldman Sachs bought 69,271 Tenet Healthcare shares in Q1 2026, an estimated $14.6M.
  • Tenet Healthcare made up 0.01% of Goldman Sachs's portfolio in Q1 2026, its #1236 holding.
  • Goldman Sachs first reported a position in Tenet Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Tenet Healthcare position peaked at $211M in Q4 2013.
  • 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.